The CEO of Roche's ​Genentech unit, Ashley Magargee, said on Monday (March 16) the company is striving to build a portfolio ...

The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job.

Some less common but serious side effects of gabapentin include suicidal thoughts, allergic reactions, and serious breathing ...

WASHINGTON - The Food and Drug Administration has launched what it is describing as a "unified dashboard" for identifying and ...

By Michele Gershberg and Michael Erman PHILADELPHIA, March 16 (Reuters) - The CEO of Roche's Genentech unit, Ashley Magargee, ...

Women are more likely to survive cancer than men but face a higher risk of serious and adverse side effects from treatment, according to a landmark international study from Adelaide University.

NEW YORK, March 16 (Reuters) - Roche's Ashley Magargee, chief executive of its Genentech unit, said on Monday the company is striving to build a portfolio of obesity medicines that are both tolerable ...

GLP-1 drugs have quickly become a top tool in the fight against obesity, but there are quite a few choices.

You might believe that Ozempic is a weight loss wonder drug, but there are a few celebrity horror stories shedding light on the reality of using GLP-1s.

While that Ozempic number is higher, it's been prescribed for a lot longer than Wegovy. Even so, the researchers found the ...

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that ...